Pharmacokinetics and safety profiles of beinaglutide injection, a Recombinant human GLP-1, in adults with overweight/obesity: results from a phase I clinical trial
In an interview with one of our Drp IV nurses she comments on IV therapy saying, I feel like its literally life changing
There are currently four popular GLP-1 agonists approved by the FDA (two FDA-approved agonists, lixisenatide and exenatide, have been discontinued in recent years)
Peptide-Based Weight Loss: Proceeding with Care With the popularity of GLP-1s, more clinics and online programs are offering quick access to weight-loss peptides
Pregnancy and breastfeeding also increase protein requirements for tissue growth and milk production
Long-Term Considerations Monitor for thyroid C-cell tumors in high-risk patients (family history), though human data remains reassuring